{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:14:31Z","timestamp":1783671271152,"version":"3.55.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873444"],"award-info":[{"award-number":["81873444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Joint Fund for Innovation and Development of Hubei Provincial Natural Science Foundation","award":["2025AFD788"],"award-info":[{"award-number":["2025AFD788"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12015-026-11171-z","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:49:15Z","timestamp":1780890555000},"page":"2965-2967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAR T-cell Therapy for Extramedullary Multiple Myeloma: from Early Response to Durable Disease Control"],"prefix":"10.1007","volume":"22","author":[{"given":"Ziyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"11171_CR1","doi-asserted-by":"crossref","unstructured":"Blade, J. (2022). Extramedullary disease in multiple myeloma: a systematic literature review. In Blood Cancer J. : United States. p. 45.","DOI":"10.1038\/s41408-022-00643-3"},{"key":"11171_CR2","doi-asserted-by":"crossref","unstructured":"Dima, D. (2024). Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. In Blood Cancer J. : United States. p. 90.","DOI":"10.1038\/s41408-024-01068-w"},{"key":"11171_CR3","doi-asserted-by":"crossref","unstructured":"Zanwar, S. (2024). Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel. In J Hematol Oncol. : England. p. 42.","DOI":"10.1200\/JCO.2024.42.16_suppl.7508"},{"issue":"12","key":"11171_CR4","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/ajh.27469","volume":"99","author":"Y Qi","year":"2024","unstructured":"Qi, Y., et al. (2024). Clinical outcomes and microenvironment profiling in relapsed\/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy. American Journal Of Hematology, 99(12), 2286\u20132295.","journal-title":"American Journal Of Hematology"},{"key":"11171_CR5","doi-asserted-by":"crossref","unstructured":"Yao, H. (2025). BCMA\/GPRC5D bispecific CAR T-cell therapy for relapsed\/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial. In J Hematol Oncol. : England. p. 56.","DOI":"10.1186\/s13045-025-01714-1"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11171-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:27:44Z","timestamp":1783668464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11171-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11171"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11171-z","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}